| Literature DB >> 24630633 |
Peggy Dartigues1, Sylvie Isaac2, Laurent Villeneuve3, Olivier Glehen4, Mathieu Capovilla5, Anne Chevallier6, Sabrina Croce7, Rachid Kaci8, Gerlinde Lang-Averous9, Marie-Hélène Laverriere10, Agnès Leroux-Broussier11, Éliane Mery12, Flora Poizat13, Séverine Valmary-Degano14, Véronique Verriele-Beurrier15, François-Noël Gilly4, Frédéric Bibeau16.
Abstract
Pseudomyxoma peritonei is a clinical entity characterized by a gelatinous ascite associated with mucinous tumor deposits spreading on peritoneal surface and potentially invading abdominal organs. It is considered as a tumor process linked, in most of cases, to a mucinous appendiceal neoplasm. Pseudomyxoma peritonei may benefit from a therapeutic strategy combining cytoreductive surgery and intra-peritoneal chemotherapy, which has led to a major prognosis improvement. Different classifications are available and the last one corresponds to the WHO 2010 version, which individualizes pseudomyxoma peritonei in two classes: low grade and high grade mucinous carcinoma. The very low frequency of this entity and its specific therapeutic strategy need specific health care centres, as well as physicians and pathologists collaborating through dedicated networks. The aim of this article is to summarize the pathology, causes, mechanisms and therapeutic approaches of pseudomyxoma peritonei, as well as their interfaces with dedicated networks.Entities:
Keywords: Appendice; Networks; Pseudomyxoma peritonei; Pseudomyxomes péritonéaux; Rares tumors; Réseaux; Tumeurs rares
Mesh:
Year: 2014 PMID: 24630633 DOI: 10.1016/j.annpat.2014.01.012
Source DB: PubMed Journal: Ann Pathol ISSN: 0242-6498 Impact factor: 0.407